HSIC - Henry Schein, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
77.48
-1.82 (-2.30%)
At close: 4:00PM EST

77.48 0.00 (0.00%)
After hours: 4:41PM EST

Stock chart is not supported by your current browser
Previous Close79.30
Open78.69
Bid74.10 x 800
Ask81.00 x 1100
Day's Range76.79 - 78.90
52 Week Range62.56 - 91.35
Volume1,828,267
Avg. Volume1,514,458
Market Cap11.811B
Beta (3Y Monthly)0.92
PE Ratio (TTM)30.29
EPS (TTM)2.56
Earnings DateFeb 18, 2019 - Feb 22, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est84.59
Trade prices are not sourced from all markets
  • PR Newswire8 hours ago

    Henry Schein Ranks First In Its Industry On List Of FORTUNE's 'World's Most Admired Companies'

    MELVILLE, N.Y., Jan. 22, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC) announced today that it ranks first in its category on the FORTUNE® "World's Most Admired Companies" list for 2019. This recognition by FORTUNE marks the 18th consecutive year that Henry Schein has been named to the overall list. Henry Schein also ranked first in the Wholesalers: Health Care industry in eight sub-categories that comprise the overall ranking: Innovation, People Management, Use of Corporate Assets, Social Responsibility, Quality of Management, Long-Term Investment Value, Quality of Products/Services, and Global Competitiveness.

  • Markit12 hours ago

    See what the IHS Markit Score report has to say about Henry Schein Inc.

    # Henry Schein Inc ### NASDAQ/NGS:HSIC View full report here! ## Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is moderate and declining ## Bearish sentiment Short interest | Positive Short interest is moderate for HSIC with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 2. ## Money flow ETF/Index ownership | Negative ETF activity is negative and may be weakening. The net inflows of $1.16 billion over the last one-month into ETFs that hold HSIC are among the lowest of the last year and appear to be slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Save the Date: Henry Schein to Host the Dental Service Organization Education Forum, Featuring a Rich Lineup of Speakers and Courses
    Business Wireyesterday

    Save the Date: Henry Schein to Host the Dental Service Organization Education Forum, Featuring a Rich Lineup of Speakers and Courses

    Henry Schein, Inc. (HSIC) today announced that it will host the 3rd annual Dental Service Organization (DSO) Education Forum, May 17-18 in Las Vegas, Nevada. This two-day event, to be held at The Aria Resort & Casino, offers three unique educational tracks designed to fit the needs of DSOs, panel discussions featuring leaders in the dental industry, and networking opportunities with DSO leaders and fellow attendees. Based on the size and type of DSO, attendees will be placed in one of the three educational tracks, which will cover different topics based on their organizational needs.

  • Business Wire4 days ago

    HENRY SCHEIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Henry Schein, Inc. - HSIC

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Henry Schein, Inc. (HSIC). On February 12, 2018, the Federal Trade Commission (“FTC”) disclosed that it had filed a complaint against the Company for violating antitrust regulations through a conspiracy with other dental supply companies agreeing to refuse to offer discounts or service to buying groups representing dental practitioners. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information, violating federal securities laws, which is ongoing.

  • Near-Term Outlook for Dental Supplies Industry Looks Bright
    Zacks4 days ago

    Near-Term Outlook for Dental Supplies Industry Looks Bright

    Near-Term Outlook for Dental Supplies Industry Looks Bright

  • Henry Schein Animal Health Spin-Off Approaches, Cost Mounts
    Zacks5 days ago

    Henry Schein Animal Health Spin-Off Approaches, Cost Mounts

    Henry Schein's (HSIC) animal health spin-off will help it boost growth opportunities in dental space to deliver quality clinical care plus advanced wellness and prevention.

  • PR Newswire6 days ago

    Henry Schein Announces New Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Health Business

    MELVILLE, N.Y. , Jan. 16, 2019 /PRNewswire/ --   Henry Schein , Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical ...

  • Markit7 days ago

    See what the IHS Markit Score report has to say about Henry Schein Inc.

    # Henry Schein Inc ### NASDAQ/NGS:HSIC View full report here! ## Summary * Bearish sentiment is moderate and declining ## Bearish sentiment Short interest | Positive Short interest is moderate for HSIC with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 2. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $14.02 billion over the last one-month into ETFs that hold HSIC are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire8 days ago

    Henry Schein and Vets First Choice Announce Board of Directors for Covetrus

    Henry Schein, Inc. (HSIC) and Vets First Choice today announced their designees who will comprise the 11-member board of directors for Covetrus, the new standalone public company that will result from the planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice. As previously announced, David E. Shaw, Co-Founder and Chairman of Vets First Choice, will become the Chairman of the Board of Covetrus.

  • Markit14 days ago

    See what the IHS Markit Score report has to say about Henry Schein Inc.

    # Henry Schein Inc ### NASDAQ/NGS:HSIC View full report here! ## Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and declining * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is moderate for HSIC with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 2. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, ETFs holding HSIC are favorable, with net inflows of $18.45 billion. Additionally, the rate of inflows is increasing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • PR Newswire15 days ago

    Henry Schein Announces Record Date, Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Health Business

    MELVILLE, N.Y., Jan. 8, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that in connection with the previously announced spin-off of its Henry Schein Animal Health Business, its Board of Directors has established January 17, 2019, as the record date (the "Record Date") and February 4, 2019, as the anticipated distribution date ("Distribution Date") for the distribution of shares of HS Spinco, Inc., the new company formed to effectuate the spin-off ("Spinco"). Spinco has filed an amended registration statement on Form S-4/S-1 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC"), which has not yet become effective, relating to the planned spin-off and subsequent merger with Direct Vet Marketing, Inc. (d/b/a Vets First Choice), which is also anticipated to be consummated on the Distribution Date.

  • HENRY SCHEIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Henry Schein, Inc. - HSIC
    PR Newswire18 days ago

    HENRY SCHEIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Henry Schein, Inc. - HSIC

    NEW ORLEANS , Jan. 4, 2019 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF ...

  • GuruFocus.com19 days ago

    5 Health Care Stocks Gurus Are Buying

    Gilead on the list

  • Markit20 days ago

    See what the IHS Markit Score report has to say about Henry Schein Inc.

    According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • GlobeNewswire22 days ago

    Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International, Eiger BioPharmaceuticals, China Automotive, and Moleculin Biotech — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, Dec. 31, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • PR Newswire27 days ago

    HS Spinco, Inc. Files Registration Statement With U.S. Securities And Exchange Commission For Spin Off Of Henry Schein's Animal Health Business And Subsequent Merger With Vets First Choice

    MELVILLE, N.Y., Dec. 26, 2018 /PRNewswire/ -- Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that HS Spinco, Inc. ("Spinco") has filed a registration statement on Form S-4/S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the planned spin off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice. Spinco intends to list its common stock on the Nasdaq Global Select Market under the symbol "CVET" and the new standalone company will be named Covetrus.

  • Business Wirelast month

    Henry Schein and Vets First Choice Announce New Name of the Planned New Company: Covetrus

    Henry Schein, Inc. (HSIC) and Vets First Choice today announced that the new standalone public company that will result from the planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice will be named Covetrus. The transaction is expected to be completed in the first quarter of 2019. The new company, Covetrus, will be a global, technology-enabled animal health business supporting the companion, equine and large-animal veterinary markets.

  • A Look At The Fair Value Of Henry Schein, Inc. (NASDAQ:HSIC)
    Simply Wall St.last month

    A Look At The Fair Value Of Henry Schein, Inc. (NASDAQ:HSIC)

    How far off is Henry Schein, Inc. (NASDAQ:HSIC) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is Read More...

  • PR Newswirelast month

    Henry Schein To Present At The 2019 J.P. Morgan Healthcare Conference

    MELVILLE, N.Y., Dec. 19, 2018 /PRNewswire/ -- Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that the Company will present at the 2019 J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019, at 2:30 p.m. Pacific time/5:30 p.m. Eastern time at the Westin St. Francis Hotel in San Francisco. Henry Schein's presentation can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations," and following the link for "Webcasts." A replay of the webcast will be available on the website following the presentation. Henry Schein, Inc. (HSIC) is a health solutions network powered by people and technology.

  • GlobeNewswirelast month

    Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Board of Directors of Henry Schein, Inc. (HSIC) and Encourages HSIC Investors to Contact the Firm

    NEW YORK, Dec. 18, 2018 -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims against certain officers and directors of Henry Schein,.

  • See what the IHS Markit Score report has to say about Henry Schein Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Henry Schein Inc.

    Henry Schein Inc NASDAQ/NGS:HSIC

  • PR Newswirelast month

    CareCredit Now Integrated Into Henry Schein's Dental And Veterinary Practice Management Software Solutions

    MELVILLE, N.Y., Dec. 17, 2018 /PRNewswire/ -- Henry Schein, Inc. (HSIC) and CareCredit, a Synchrony (SYF) solution and a leading provider of patient financing, today announced the integration of CareCredit's financing tool into Henry Schein's dental and veterinary practice management software solutions. CareCredit integrates into Dentrix® and Easy Dental®, practice management software solutions offered to dental professionals by Henry Schein One, a joint venture of Henry Schein.

  • Business Wirelast month

    HENRY SCHEIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Henry Schein, Inc. - HSIC

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Henry Schein, Inc. (HSIC). On February 12, 2018, the Federal Trade Commission (“FTC”) disclosed that it had filed a complaint against the Company for violating antitrust regulations through a conspiracy with other dental supply companies agreeing to refuse to offer discounts or service to buying groups representing dental practitioners. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information, violating federal securities laws, which is ongoing.

  • Should You Buy Henry Schein, Inc. (HSIC)?
    Insider Monkeylast month

    Should You Buy Henry Schein, Inc. (HSIC)?

    “Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting active opportunities away from the index are growing. At some point, this fault line will break, likely on the back of rising rates, and all investors will be reminded that the best time […]

  • PR Newswirelast month

    Henry Schein Announces $400 Million Increase To Share Repurchase Plan

    MELVILLE, N.Y., Dec. 13, 2018 /PRNewswire/ -- Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company's common stock. The Company had approximately 153 million shares outstanding as of December 12, 2018. This new authorization represents approximately 3.0 percent of shares outstanding at the current stock price.